Synthetic Biologics, Inc. (NYSE MKT: SYN) is a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients. The Company's lead candidates poised for Phase 3 development are: (1) SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and (2) SYN-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C. difficile infection (CDI), antibiotic-associated diarrhea (AAD) and the emergence of antimicrobial-resistance (AMR). The Company is also developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria (PKU).
View Top Employees from Synthetic Biologics, Inc.| Website | http://www.syntheticbiologics.com |
| Ticker | SYN |
| Revenue | $5.4 million |
| Employees | 17 (2 on RocketReach) |
| Founded | 2001 |
| Address | 9605 Medical Center Dr Ste 270, Rockville, Maryland 20850, US |
| Phone | (301) 417-4364 |
| Fax | (301) 417-4367 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Microbiome, Healthcare, Science and Engineering, Prevention of C. dificile Infection, Health Care, Irritable Bowel Syndrome with Constipation (IBS-C), Therapeutics |
| Web Rank | 10 Million |
| Keywords | Synthetic Biologics, Syntheticbiology Inc, Syn, Key Opinion Leaders In Gastroenterology, Human Heart Dotted Diagram |
| Competitors | ALX Oncology, Applied Therapeutics Inc, Aptahem, Cerecor, Inc., Helix Biopharma Corp (HBPCF) |
| SIC | SIC Code 28 Companies, SIC Code 873 Companies, SIC Code 283 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325412 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies |
Looking for a particular Synthetic Biologics, Inc. employee's phone or email?
Synthetic Biologics, Inc. Questions
The Synthetic Biologics, Inc. annual revenue was $5.4 million in 2023.
Charles L is the Vice President, Statistics, Programming and Data Manageme of Synthetic Biologics, Inc..
2 people are employed at Synthetic Biologics, Inc..
Synthetic Biologics, Inc. is based in Rockville, Maryland.
The NAICS codes for Synthetic Biologics, Inc. are [32541, 325, 325412, 3254, 541, 54, 32].
The SIC codes for Synthetic Biologics, Inc. are [28, 873, 283, 87].
Top Synthetic Biologics, Inc. Employees
Related Companies
